The main precautionary note for GHK-Cu concerns individuals with known copper metabolism disorders or Wilsons disease, for whom any additional copper loading, including from GHK-Cu, would be contraindicated
Each state Medicaid program sets its own rates, coverage policies, and prior authorization requirements independently
Supplier Credibility and Regulation We source all medications and adjunct therapies from reputable, licensed suppliers
Peptide therapeutics are not an exotic category that mainstream drug development cannot handle
Human data remain limited, and most studies are small, single-center, or use copper peptide formulations combined with other ingredients (which makes it hard to isolate GHK-Cu's specific contribution): A 2016 Lee et al